Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of MicroRNA Biomarkers for Alzheimer’s Disease in Human Cerebrospinal Fluid

22 Jan 2019

Abstract excerpt

We previously discovered microRNAs (miRNAs) in cerebrospinal fluid (CSF) that differentiate Alzheimer's disease (AD) patients from Controls. Here we examined the performance of 37 candidate AD miRNA biomarkers in a new and independent cohort of CSF from 47 AD patients and 71 Controls on custom TaqMan arrays. We employed a consensus ranking approach to provide an overall priority score for each miRNA, then used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30689565
DOI: 10.3233/jad-180539

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of MicroRNA Biomarkers for Alzheimer’s Disease in Human Cerebrospinal FluidPMID 30689565Read ↗

MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.Semantic proximity Read ↗

MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseaseSemantic proximity Read ↗

Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer’s DiseaseSemantic proximity Read ↗

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)Semantic proximity Read ↗

Cerebrospinal fluid CD4+ T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer's disease biomarkersSemantic proximity Read ↗

Plasma microRNAs as potential biomarkers in early Alzheimer disease expressionSemantic proximity Read ↗

Literature-Identified Serum miRNA Signatures for Cognitive Decline: Integrated Analysis and Machine-Learning Diagnostics in Alzheimer’s DiseaseSemantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

A blood based 12-miRNA signature of Alzheimer disease patientsSemantic proximity Read ↗

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesSemantic proximity Read ↗

Machine learning to detect Alzheimer’s disease from circulating non-coding RNAsSemantic proximity Read ↗

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.